SCHEMBL7357010

SCHEMBL7357010

CCOC(=O)c1ccccc1Cn1c(=O)c(=O)[nH]c2cc([N+](=O)[O-])ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.47
GRIK2 Q13002 1/20 0.47
GRIK3 Q13003 1/20 0.47
GRIK4 Q16099 1/20 0.47
GRIK5 Q16478 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
ELANE P08246 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
GRIA4 P48058 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7354860 0.93 GRIK1 (0.47) GRIK1GRIK2GRIK3GRIK4GRIK5
SCHEMBL7947015 0.88 CYP1A2 (0.48) MEN1KMT2APOLBELANELMNA
SCHEMBL7349744 0.86 GRIK1 (0.45) GRIK1GRIK2GRIK3GRIK4GRIK5
SCHEMBL7359747 0.78 PGR (0.45) GRIK1GRIK2GRIK3GRIK4GRIK5
SCHEMBL7353360 0.77 GRIK1 (0.59) GRIK1GRIK2GRIK3GRIK4GRIK5
SCHEMBL9395755 0.76 PGR (0.54) MEN1KMT2AALDH1A1GRIA1GRIA2
SCHEMBL8609548 0.76 CYP1A2 (0.57) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL7474077 0.75 SERPINE1 (0.51) ELANESMN1; SMN2MAPTNOD2NOD1
SCHEMBL7349752 0.75 ALDH1A1 (0.54) MEN1KMT2APOLBELANELMNA
SCHEMBL7352546 0.75 PARG (0.47) MEN1KMT2APOLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288065-B1 CENTRAL NERVOUS SYSTEM DISORDERS; PARKINSON*S AND ALZHEIMER*S DISEASE SCHERING AKTIENGESEELLSCHAFT (DE) 2001-09-11 US disclosed
US-6057304-A Quinoxaline-phosphonic acid derivatives SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-02 US disclosed